Cardiac Autonomic Neuropathy and Early Progressive Renal Decline in Patients with Nonmacroalbuminuric Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Cardiac autonomic neuropathy predicts future adverse renal outcomes in the general population. This study sought to determine its relationship with early progressive renal decline in type 1 diabetes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A subset of participants with normoalbuminuria (n=204) or microalbuminuria (n=166) from the First Joslin Kidney Study underwent assessment for cardiac autonomic neuropathy using heart rate variability during baseline visits performed from January 1991 to April 1992. Cardiac autonomic neuropathy was defined as an R-R variation (mean circular resultant) <20. Participants also had baseline and follow-up measurement of eGFR. Early progressive renal decline was evaluated according to two definitions: early GFR loss (slope of eGFR estimated by cystatin C <-3.3%/year) and incident advanced CKD (stage ≥3, defined by eGFR [calculated by Modification of Diet in Renal Disease method] <60 ml/min per 1.73 m(2)). Association with baseline cardiac autonomic neuropathy was assessed by adjusted logistic regression and Cox proportional hazards. RESULTS: Among the 370 participants, 47 (13%) had baseline cardiac autonomic neuropathy, 51 (14%) had early GFR loss, and 68 (18%) had incident advanced CKD over a median 14-year follow-up. Early GFR loss occurred in 15 (32%) of the 47 patients with baseline autonomic neuropathy and in 32 (10%) of the 323 without baseline autonomic neuropathy (P<0.001). Baseline autonomic neuropathy was strongly associated with odds of early GFR loss (adjusted odds ratio, 4.09; 95% confidence interval, 1.65 to 10.12; P=0.002). Incident advanced CKD was observed in 22 (47%) of those with baseline autonomic neuropathy and 46 (14%) of those without baseline autonomic neuropathy (P<0.001). Autonomic neuropathy was independently associated with incident advanced CKD (adjusted hazard ratio, 2.76; 95% confidence interval, 1.44 to 5.30; P=0.002). CONCLUSIONS: Cardiac autonomic neuropathy was a strong independent predictor of the long-term risk of early progressive renal decline in type 1 diabetes. Future research should explore the mechanisms by which autonomic neuropathy may be associated with renal function loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Timely detection of CAN may help implementation of tailored interventions to prevent its progression and mitigate the risk of associated complications, including CVD, cardiac arrhythmias, myocardial dysfunction leading to congestive heart failure (CHF), CKD, and all-cause mortality.547,614,617–625”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [621]
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402670 · Cited by 2,186
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036 · cited 1×
“Finally, the overall prevalence of DN continues to increase in proportion to the rising prevalence of diabetes (3,8).”
BackgroundAlbuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
Ninomiya, T., Perkovic, V., de Galan, B. E., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121270 · Cited by 965
Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957 · cited 2×
“001 Early GFR loss, n (%) 15 (32) 36 (11) ,0.”
BackgroundSelf-citationRegression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 801
Self-citationIncrease in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes
Lurbe, E., Redon, J., Kesani, A., Pascual, J. M., Tacons, J., Alvarez, V., & Batlle, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013410 · Cited by 729
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Maser, R. E., Mitchell, B. D., Vinik, A. I., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1895 · Cited by 578
Research works printed but not linked: 1
- Low, 1997, Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects., Muscle Nerve, 20, 1561, 10.1002/(SICI)1097-4598(199712)20:12<1561::AID-MUS11>3.0.CO;2-3 · doi:10.1002/(sici)1097-4598(199712)20:12<1561::aid-mus11>3.0.co;2-3
Cited by
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
Self-citationDiabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationSpallone, V. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0259 · Cited by 295
The neurovascular unit and the pathophysiologic basis of diabetic retinopathy
Gardner, T. W., & Davila, J. R. (2017) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3548-y · Cited by 193
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression
Wang, N., & Zhang, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063086 · Cited by 139
Duque, A. P., Mediano, M. F. F., Lorenzo, A. D., & Rodrigues, L. F. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.855 · Cited by 114
Jaiswal, M., Divers, J., Urbina, E. M., Dabelea, D., Bell, R. A., Pettitt, D. J., Imperatore, G., Pihoker, C., Dolan, L. M., Liese, A. D., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12633 · Cited by 90
Self-citationBlood Pressure Variability and Autonomic Dysfunction
Spallone, V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1108-z · Cited by 85
Mathew, A. V., Jaiswal, M., Ang, L. P., Michailidis, G. C., Pennathur, S., & Pop‐Busui, R. (2019) · Diabetes · doi:10.2337/db19-0145 · Cited by 71
Self-citationUpdate on the Management of Diabetic Neuropathy
Ang, L., Cowdin, N., Mizokami-Stout, K., & Pop-Busui, R. (2018) · Diabetes Spectrum · doi:10.2337/ds18-0036 · Cited by 55
Self-citationCardiovascular autonomic neuropathy: A silent killer with long reach
Ang, L., Dillon, B., Mizokami-Stout, K., & Pop-Busui, R. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102646 · Cited by 53
Self-citationKobayashi, H. H., Looker, H. C., Satake, E., Saulnier, P., Dom, Z. I. M., O’Neil, K. V., Ihara, K., Krolewski, B., Gałecki, A. T., Niewczas, M. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.04.022 · Cited by 54
Cho, Y. H., Craig, M. E., Jopling, T., Chan, A. K. F., & Donaghue, K. C. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12642 · Cited by 37
Dafaalla, M. D., Nimir, M., Mohammed, M. I., Ali, O., & Hussein, A. (2016) · Open Heart · doi:10.1136/openhrt-2015-000336 · Cited by 33
Arrhythmias in Chronic Kidney Disease
Akhtar, Z., Leung, L. W. M., Kontogiannis, C., Chung, I., Waleed, K. B., & Gallagher, M. M. (2022) · European Cardiology Review · doi:10.15420/ecr.2021.52 · Cited by 35
Wheelock, K. M., Jaiswal, M., Martin, C. L., Fufaa, G. D., Weil, E. J., Lemley, K. V., Yee, B., Feldman, E., Brosius, F. C., Knowler, W. C., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.03.008 · Cited by 24
“Persons with either type 1 or type 2 diabetes who also have CAN have a faster rate of renal function decline than those who do not (4–7), suggesting an association between these complications (4–13) which may be attributable to CAN-induced changes in renal hemodynamics (7, 9, 11, 12).”
BackgroundSelf-citationSoomro, Q. H., & Charytan, D. M. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000686 · Cited by 24
Tang, Y., Ang, L. P., Jaiswal, M., Dillon, B. R., Esfandiari, N. H., Shah, H., Spino, C., Plunkett, C., Perkins, B. A., Pop‐Busui, R., et al. (2023) · Diabetes · doi:10.2337/db23-0247 · Cited by 25
Self-citationBjerre‐Christensen, T., Winther, S. A., Tofte, N., Theilade, S., Ahluwalia, T. S., Lajer, M., Hansen, T. W., Rossing, P. R., & Hansen, C. S. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002289 · Cited by 20
Hansen, C. S., Suvitaival, T., Theilade, S., Mattila, I. M., Lajer, M., Trôst, K., Ahonen, L. L., Hansen, T. W., Legido‐Quigley, C., Rossing, P. R., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.831793 · Cited by 19
Mangelis, A., Fountoulakis, N., Corcillo, A., Collins, J., Vas, P. R. J., Hussain, S., Hopkins, D., Gnudi, L., Thomas, S., Ayis, S. A., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0815 · Cited by 19
Risk factors for rapid kidney function decline in diabetes patients
Xing, J., Huang, L., Ren, W., & Mei, X. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2398188 · Cited by 17
Detecting and treating the protean manifestations of diabetic autonomic neuropathy
Bell, D. S. H. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15004 · Cited by 19
Didangelos, T., Moralidis, E., Karlafti, E., Τζιόμαλος, Κ., Margaritidis, C., Kontoninas, Z., Stergiou, I., Boulbou, M., Papagianni, M., Papanastasiou, E., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/5607208 · Cited by 14
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes
Ang, L. P., GUNARATNAM, S. V. G., Huang, Y., Dillon, B. R., Martin, C. L., Burant, A., Reiss, J., Blakely, P. K., Vasbinder, A. L., Zhao, L., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036787 · Cited by 18
Self-citationNondipping heart rate and associated factors in patients with chronic kidney disease
Bıyık, Z., Yavuz, Y. C., Altıntepe, L., Çelik, G., Güney, İ., & Oktar, S. F. (2019) · Clinical and Experimental Nephrology · doi:10.1007/s10157-019-01782-x · Cited by 12
Cardiovascular autonomic neuropathy and the risk of diabetic kidney disease
Cho, I., Lim, S., Kwon, M., Chung, S. M., Moon, J. S., Yoon, J. S., & Won, K. C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1462610 · Cited by 13
Cardiac autonomic neuropathy in nonobese young adults with type 1 diabetes
Kim, H. Y., Jung, H. W., Lee, Y. A., Shin, C. H., & Yang, S. W. (2019) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2019.24.3.180 · Cited by 12
Laursen, J. C., Hansen, C. S., Bordino, M., Vistisen, D., Zobel, E. H., Winther, S. A., Groop, P., Frimodt‐Møller, M., Bernardi, L., & Rossing, P. R. (2020) · Diabetic Medicine · doi:10.1111/dme.14315 · Cited by 11
Baroreceptor Sensitivity in Individuals with CKD and Heart Failure
Charytan, D. M., Soomro, Q. H., Caporotondi, A., Guazzotti, G., Maestri, R., Pinna, G. D., & Rovere, M. T. L. (2022) · Kidney360 · doi:10.34067/kid.0004812022 · Cited by 11
Sokolovska, J., Stefanovics, J., Gersone, G., Pahirko, L., Valeinis, J., Kalva-Vaivode, S., Rovīte, V., Blumfelds, L., Pīrāgs, V., & Tretjakovs, P. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1079-4711 · Cited by 10
Zeng, H., Liu, J., Chen, Z., Yu, P., & Liu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.900465 · Cited by 9
Velayutham, V., Benitez‐Aguirre, P., Craig, M. E., Cho, Y. H., Liew, G., & Donaghue, K. C. (2022) · Diabetes Care · doi:10.2337/dc22-0349 · Cited by 11
Júnior, C. R. B., Bano, A., Tang, Y., Sun, X., Abate, A., Hall, E., Mitri, J., Morieri, M. L., Shah, H., & Doria, A. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01869-6 · Cited by 12
Pedrosa, H. C., Braver, J. D., Rolim, L. C., Schmid, H., Calsolari, M. R., & Odriozola, A. (2019) · Alad · doi:10.24875/alad.18000352 · Cited by 6
Soe, K. K., & Selvarajah, D. (2025) · Kidney Medicine · doi:10.1016/j.xkme.2025.101149 · Cited by 6
Yang, X., Lin, Q., Li, X. A., Wu, L., Xu, W., Zhu, Y., Deng, H., Zhang, Y., & Yao, B. (2019) · Journal of Diabetes Research · doi:10.1155/2019/1706964 · Cited by 7
Huang, X., Bao, Y., Wang, J., & Tian, L. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2507244 · Cited by 5
Diabetic kidney disease and cardiac autonomic neuropathy: insights on exercise rehabilitation
Michou, V., Tsamos, G., Vasdeki, D., Kouidi, E. J., & Deligiannis, A. P. (2025) · Journal of Nephrology · doi:10.1007/s40620-025-02216-6 · Cited by 2
Diagnosis and Management of Diabetic Autonomic Neuropathy
Kim, C. H. (2018) · Journal of Korean Diabetes · doi:10.4093/jkd.2018.19.3.160 · Cited by 2
Choi, M. S., Jun, J. E., Park, S. W., Yoo, J. H., Ahn, J., Kim, G., Jin, S., Hur, K. Y., Lee, M., & Kim, J. H. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0211 · Cited by 2
Toshniwal, S. S., Kumar, S., Acharya, S., Ghali, A., Raut, S. S., Deolikar, V., Reddy, H., Kotak, P. S., Wanjari, A., & Bawankule, S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1514214 · Cited by 1
Soe, K. K., Robinson, E., Oleolo, M., Goonoo, M. S., SLOAN, G. P., Heller, S. R., Tesfaye, S. H., Marques, J. L. B., Sourbron, S. P., & Selvarajah, D. (2026) · Diabetologia · doi:10.1007/s00125-026-06818-y · Cited by 2
Padmini, S., Pulichikkat, R., Menon, S. V., & Abbas, R. (2017) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2017/154 · Cited by 1
Lin, Y. K., Tanner, E. C., Wang, Y., Ye, W., Ang, L. P., Ju, W., & Pop‐Busui, R. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14049 · Cited by 1
Self-citationRelations entre gain baroréflexe et autres marqueurs de risque chez le patient diabétique de type 2
Philips, J. C., Marchand, M., & Scheen, A. J. (2016) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2016.09.038 · Cited by 1
Cardiovascular Autonomic Neuropathy
Ang, L. P., & Pop‐Busui, R. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_12 · Cited by 2
Self-citationHansen, C. S., Suvitaival, T., Theilade, S., Mattila, I. M., Lajer, M., Trôst, K., Ahonen, L. L., Hansen, T. W., Legido‐Quigley, C., Rossing, P. R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.18.444673
On the sustainable development of small island developing nations in the Pacific region
Eddington, I. (2006) · University of Southern Queensland ePrints (University of Southern Queensland)
Pelaes, T. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-05042022-140056 · Cited by 1
Cardiac autonomic neuropathy as risk factor of diabetic complications progression
Салухов, В. В., Zelenina, T. A., Денисович, И. Д., & Ab, Z. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-161
Xuan, M., Shen, Y., Tang, W., Fang, P., Liu, G., Li, G., Sun, Q., & Pan, L. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01862-x
Nonblood/Urine Biomarker of Progression of Kidney Disease in Diabetes Mellitus
Tolouian, R., & Vinik, A. I. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05640515
Bueno Junior, C. R., Bano, A., TANG, Y., SUN, X., Abate, A., Hall, E., Mitri, J., Morieri, M. L., Shah, H., & Doria, A. (2023) · Figshare · doi:10.6084/m9.figshare.23583664
Rezidivierende akute Nierenschädigung mit Schwindel – eine unterdiagnostizierte Gefahr bei Diabetes
Turkiewicz, A., Arnhold, F., Mertens, P. R., & Bender, S. T. (2026) · Die Nephrologie · doi:10.1007/s11560-026-00954-7
The Associations of Heart Rate Variability With Inflammatory Biomarkers
Moloney, B. M., Correa, S., Song, E. H., Chertow, G. M., & Causland, F. R. M. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.107133
Metadata
- Authors
- Orlov, S., Cherney, D. Z. I., Pop-Busui, R., Lovblom, L. E., Ficociello, L. H., Smiles, A. M., Warram, J. H., Krolewski, A. S., & Perkins, B. A.
- Affiliations
- Mount Sinai Hospital (CA)
- University of Toronto (CA)
- Joslin Diabetes Center (US)
- Corresponding author
- Orlov, Steven
- Lovblom, Leif E.
- Perkins, Bruce A.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2015-07
- Volume
- 10
- Issue
- 7
- Pages
- 1136-1144
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC4491301
- OpenAlex
- W2401113515
- Cited by
- 57
- References
- 50
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 8 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 6 · 2017: 1 · 2016: 5 · 2015: 1
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Toronto
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-41526, R01DK041526, P30DK020572)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- neuropathy, type 1 diabetes, diabetic nephropathy, heart rate variability, microalbuminuria, normoalbuminuria, chronic kidney disease progression, estimated glomerular filtration rate decline, cystatin C, cardiovascular risk stratification
- MeSH terms
- Adolescent, Adult, Autonomic Nervous System, Boston, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Diabetic Neuropathies, Female, Follow-Up Studies, Glomerular Filtration Rate, Heart, Heart Rate, Humans, Kidney, Male, Prospective Studies, Risk Factors, Time Factors, Biomarkers, Incidence, Multivariate Analysis, Logistic Models, Proportional Hazards Models, Odds Ratio, Disease Progression, Cystatin C, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.